Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
"Patients often require intensive hospital care as symptoms worsen, and our current treatment options are severely limited," explains Igdoura. "But now, there's hope." By studying late-onset cases, ...
The jail in Georgia's largest county, Fulton County, leaves its inmates vulnerable to "substantial risk of serious harm from ...
NATO and the European Union are ramping up efforts to persuade China to help get North Korea to stop sending troops and other ...
New storms in Spain caused school closures and train cancellations on Wednesday, two weeks after flash floods in Valencia and ...
A 6-year-old boy from Tennessee has already set his sights on a career as a thoracic surgeon, inspired by a Northwestern ...
Some ways to protect yourself from pneumonia are: Make sure you’re up to date on your immunizations. Practice good health ...
About 35% of patients diagnosed with cancer in Ontario had previously visited an emergency department, raising questions about access to routine care and oncology services.
Dizziness when lying down may be treatable with head positioning and medications. This article describes non-emergency and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback